SCHEMBL8868488

SCHEMBL8868488

COc1ccc(Cl)c(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)c3ccc(C(=O)NCC(=O)O)nc3)cc2)c1

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.51
ALDH1A1 P00352 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
MAPT P10636 1/20 0.51
P4HTM Q9NXG6 1/20 0.51
KMT2A Q03164 2/20 0.49
MEN1 O00255 1/20 0.49
HTT P42858 1/20 0.49
NLRP3 Q96P20 2/20 0.45
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
EGLN1 Q9GZT9 1/20 0.44
RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8868784 0.94 P4HTM (0.51) LMNAALDH1A1SMN1; SMN2MAPTP4HTM
SCHEMBL8869766 0.93 P4HTM (0.53) LMNAALDH1A1SMN1; SMN2MAPTP4HTM
SCHEMBL8869039 0.93 LMNA (0.53) LMNAALDH1A1SMN1; SMN2MAPTP4HTM
SCHEMBL8867559 0.92 NLRP3 (0.54) LMNAALDH1A1MAPTP4HTMKMT2A
SCHEMBL8868729 0.92 P4HTM (0.52) LMNAALDH1A1SMN1; SMN2MAPTP4HTM
SCHEMBL8868577 0.91 P4HTM (0.53) LMNAALDH1A1SMN1; SMN2MAPTP4HTM
SCHEMBL8868489 0.90 P4HTM (0.47) LMNAALDH1A1SMN1; SMN2MAPTP4HTM
SCHEMBL8868823 0.90 SMN1; SMN2 (0.50) LMNAALDH1A1SMN1; SMN2MAPTP4HTM
SCHEMBL8868484 0.90 ALDH1A1 (0.48) LMNAALDH1A1SMN1; SMN2MAPTP4HTM
SCHEMBL8869989 0.89 P4HTM (0.59) LMNAALDH1A1MAPTP4HTMKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed